HDMA - Task Forces - Product Safety Task Force

Anti-Counterfeiting Controlled Substances Emergency Preparedness Flu Vaccine HDMA PAC HDMA State LawBooks Log Into HDMA State LawBooks Importation Internet Pharmacy Legislative Center Patient Privacy and Confidentiality Prescription Drug Pedigree Requirements Tax Legislation Additional HDMA Federal Agency Activities News Center Press Room Vital Link Annual Leadership Forum Distribution Management Conference & Expo Business Partners Exchange Regional Roundtable Meetings RFID/Track & Trace Health Care Summit Upcoming Meetings & Conferences Webinars Education Webinars Seminars Anti-Counterfeiting Barcoding Biotechnology Contract
Administration/Chargebacks Controlled Substances Ordering
System (CSOS) Electronic Data Interchange (EDI) Electronic Product Code (EPC) Product Availability/Drug Shortages HDMA Distribution Digest HDMA New Rx Product Introduction Form HDMA State LawBooks Log Into HDMA State LawBooks Industry Acronyms Industry Analysts Industry News Links Industry Statistics Industry Web Links Links to State Legislatures Award Programs Member Companies HDMA Directory HDMA Antitrust Policy Sponsorship Opportunities Advertising Opportunities



> Import Safety Summit > HDMA Commends Introduction of HR 6353 > HDMA Commends House Committee Chairmen > HDMA FDAAA Comments > HDMA Testifies Supporting HR5839 print page

Task Forces

Product Safety Task Force
The Product Safety Task Force (PSTF) was created by HDMA in response to FDA�s anti-counterfeiting initiative. As part of FDA�s goal, they wish to work with industry as a sounding board on ideas, suggestions, and possible strategies. The PSTF was formed to serve this role, thus acting as a broad, industry-wide coalition to assist FDA.

The PSTF is made up of healthcare manufacturers, distributors, pharmacies, retailers, industry associations, and standards bodies. The FDA also attends meeting in a liaison role. An initial kick-off meeting was held in August 2003, and since then the group has conducted numerous virtual meetings and physically met when appropriate. Additional virtual meetings and face-to-face meetings will be held as necessary throughout 2004.

The overall goal of the PSTF is to provide the healthcare industry with the business requirements for a track and trace functionality that will ultimately combat counterfeit product. In addition, the group provided a response to both the FDA�s 60-day Interim Report on Counterfeiting, as well as the Final Report released in February of 2004. The final goal that the group has identified is to develop a migration path showing how to move from the current barcode technologies to full electronic track and trace technologies, and the timeline associated with steps along that path.

General Information:

PSTF Roster